USDA’s Equine 2026 Study to Reveal Emerging Disease Trends and Boost Horse Sector Biosecurity
The USDA prepares to launch its comprehensive Equine 2026 Study, aiming to map health, welfare, and management trends across the US horse industry, enhancing disease prevention and policy planning.
The US Department of Agriculture is preparing to launch its Equine 2026 Study in August, part of the National Animal Health Monitoring System’s effort to map health, welfare and management trends across the country’s horse sector.
The voluntary, confidential survey will proceed in two stages: first a national farm questionnaire, then on-site sampling at equine events to identify disease risks. The USDA says the work is intended to give policymakers and industry leaders a clearer evidence base for decisions on research, veterinary provision, biosecurity and emergency planning.
Nathaniel A White II, professor emeritus of equine surgery at Marion duPont Scott Equine Medical Centre and a former president of the American Association of Equine Practitioners, told HPJ the exercise follows earlier NAHMS studies in 1998, 2005 and 2015. He said the findings will help define disease prevalence and guide investment in future research, health care and disaster response.
Katie Flynn, senior staff veterinarian for equine health and biosecurity at the United States Equestrian Federation, said the 2005 event study has remained a useful benchmark for assessing risks at horse gatherings. She added that the 2026 work should sharpen understanding of current infectious-disease threats and prevention measures.
Participating states include 29 states spanning the West Coast, Great Plains, Midwest, South and parts of the East Coast. NAHMS said privacy will be protected and urged owners to take part when invitations are issued.
"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."